纳呋拉啡
中文名称:纳呋拉啡
英文名称:NALFURAFINE
CAS号:152657-84-6
分子式:C28H32N2O5
分子量:476.56
EINECS号:
Mol文件:152657-84-6.mol
纳呋拉啡 性质
| 沸点 | 700.7±60.0 °C(Predicted) |
|---|---|
| 密度 | 1.41±0.1 g/cm3(Predicted) |
| 储存条件 | Store at -20°C |
| 溶解度 | 二甲基亚砜：10mM |
| 形态 | 结晶固体 |
| 酸度系数(pKa) | 9.37±0.60(Predicted) |
纳呋拉啡 用途与合成方法
Nalfurafine (TRK-820) 是一种强效选择性，具有口服活性的 G 蛋白偏倚 kappa opioid receptor (KOR) 激动剂，具有很高的转化潜力。Nalfurafine (TRK-820) 增强了 MOR 靶向镇痛药的生物学作用，它还有潜力用于尿毒症瘙痒研究的相关研究。
IC50: kappa opioid receptor (KOR)
Nalfurafine (subcutaneous injection; 0.015 mg/kg) combines with EOM-salvinorin-B produces spinal antinociception equivalent to 5 mg/kg, it also enhances the supraspinal analgesic effect of 5 mg/kg morphine. Nalfurafine (subcutaneous injection; 4 μg/kg) causes a dose-dependent increase of the inhibition of the acetic acid-induced abdominal constriction,and the inhibition of the abdominal constriction reaches its peak 30 min after injection, gradually declined and returned to the preinjection level 4 hr after.
| Animal Model: | Male and Female C57BL/6J mice |
| Dosage: | 0.015 mg/kg |
| Administration: | Subcutaneous injection |
| Result: | Had the potential for enhancing the therapeutic potential of MOR-targeting analgesics, such as morphine. |
